China Biologic Products EBITDA margin
¿Qué es el EBITDA margin de China Biologic Products?
El EBITDA margin de China Biologic Products Holdings, Inc. es 42.45%
¿Cuál es la definición de EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin de compañías en Sector Miscellaneous en LSE en comparadas con China Biologic Products
Empresas con ebitda margin similar a China Biologic Products
- Legacy Housing tiene EBITDA margin de 42.33%
- Amerigo Resources tiene EBITDA margin de 42.34%
- ACNB tiene EBITDA margin de 42.36%
- Pharos plc tiene EBITDA margin de 42.37%
- Lilis tiene EBITDA margin de 42.40%
- Silvercorp Metals tiene EBITDA margin de 42.44%
- China Biologic Products tiene EBITDA margin de 42.45%
- United Overseas Bank (Singapore) tiene EBITDA margin de 42.46%
- First Bancshares Inc Miss tiene EBITDA margin de 42.50%
- WEC Inc tiene EBITDA margin de 42.51%
- National Grid Plc tiene EBITDA margin de 42.51%
- PetroShale tiene EBITDA margin de 42.52%
- Divi's Laboratories tiene EBITDA margin de 42.52%